Skip to main content

Financial News

  • Innovation, performance, value keys to foot care

    The foot care category is still dominated by Bayer Consumer’s Dr Scholl’s, which generated $291.9 million in sales for the 52 weeks ended June 4, on a 6.8% decline, according to Nielsen data as provided by Implus. Store brands gained 7.4% in that time frame to $65.6 million, and Implus gained 47.5% with the Airplus brand to $40.7 million.

  • New products boost external analgesic rubs

    Quest Products is looking to break onto the external analgesic scene with CopperFixx, a balm that combines the analgesic properties associated with copper and arnica. “Copper has always been known to help relieve the aches and pains of certain afflictions,” said Don Ryan, president and CEO of Quest Products. “Until now, no one had figured out how to produce it in a consumer-friendly form.”

  • Following disappointing quarter, new Fred's CEO focuses on future

    MEMPHIS, Tenn. - Fred's Super Dollar on Tuesday reported a decline in total sales of 3% for the second quarter ended July 30, though the company posted total sales increases of 2.3% for the first half of 2016 as compared to the year-ago period.

  • Walmart U.S. drives 3.1% gain in net Q2 sales

    BENTONVILLE, Ark. - Walmart U.S. on Thursday posted a 3.1% lift in net sales for its second quarter ended July 29 to $76.2 billion and delivered positive comp sales for the eighth consecutive quarter, up 1.6%, along with the seventh consecutive quarter of positive traffic, which was up 1.2%.

    Net sales at Sam's Club for the period were down 1.3% to $14.5 billion with a slight 0.6% gain in comparable sales (excluding fuel) and a slight 0.4% decline in overall traffic. Net sales, without fuel, grew by 0.4%, Walmart reported.

  • Target Q2 earnings fall but top Street; plants red flag for full year

    Target Corp. on Wednesday reported second quarter earnings that exceeded Wall Street expectations, but the discounter lowered its guidance for the full year amid declining sales and what it called a “difficult retail environment.”
     

  • Walmart buying Jet.com for $3 billion

    Walmart Stores announced it will acquire retail start-up — and would-be Amazon rival — Jet.com for approximately $3 billion in cash. Additionally, $300 million of Walmart shares will be paid over time as part of the transaction.
     
    The deal will go a long way to helping Walmart expand its e-commerce growth and customer reach, and also give it more firing power as it competes with Amazon.  And Jet.com’s popularity with millennials will help the discounter attract a younger, higher-income customer. 

  • CVS Health adjusted earnings for Q2 exceed analyst estimates

    WOONSOCKET, R.I. - CVS Health on Tuesday reported an increase of 17.6% in net revenues for the three months ended June 30, 2016, to $43.7 billion. Revenues in the Pharmacy Services Segment increased 20.7% to $29.5 billion in the three months ended June 30, 2016, which CVS Health attributed to an increased pharmacy network claim volume and growth in specialty pharmacy.

  • Flonase continues market strength

    GSK Consumer Healthcare’s Flonase allergy remedy was the single greatest generator of incremental dollars for the 52 weeks ended May 15 across total U.S. multi-outlets, according to IRI data, with $345.2 million in sales on 209.9% growth. The question headed into its second year on OTC shelves is can it maintain its momentum now that private-label competition for Flonase has reached store shelves.

X
This ad will auto-close in 10 seconds